Guibourdenche, J.; Leguy, M.-C.; Pidoux, G.; Hebert-Schuster, M.; Laguillier, C.; Anselem, O.; Grangé, G.; Bonnet, F.; Tsatsaris, V.
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. Int. J. Mol. Sci. 2023, 24, 7669.
https://doi.org/10.3390/ijms24087669
AMA Style
Guibourdenche J, Leguy M-C, Pidoux G, Hebert-Schuster M, Laguillier C, Anselem O, Grangé G, Bonnet F, Tsatsaris V.
Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. International Journal of Molecular Sciences. 2023; 24(8):7669.
https://doi.org/10.3390/ijms24087669
Chicago/Turabian Style
Guibourdenche, Jean, Marie-Clémence Leguy, Guillaume Pidoux, Marylise Hebert-Schuster, Christelle Laguillier, Olivia Anselem, Gilles Grangé, Fidéline Bonnet, and Vassilis Tsatsaris.
2023. "Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta" International Journal of Molecular Sciences 24, no. 8: 7669.
https://doi.org/10.3390/ijms24087669
APA Style
Guibourdenche, J., Leguy, M. -C., Pidoux, G., Hebert-Schuster, M., Laguillier, C., Anselem, O., Grangé, G., Bonnet, F., & Tsatsaris, V.
(2023). Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. International Journal of Molecular Sciences, 24(8), 7669.
https://doi.org/10.3390/ijms24087669
